
Alexandria Real Estate has declined 75% in five years due to oversupply, higher rates, and a biotech funding slowdown. Despite recent negative rental rate changes and falling occupancy, ARE's best-in-
PASADENA, Calif., Sept. 4, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™
PASADENA, Calif., Aug. 12, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $1,000,000,000
Alexandria Real Estate Equities is mispriced as a distressed office REIT, offering a 'Strong Buy' opportunity. ARE's specialized life sciences campuses in top biotech hubs anchor high-quality tenants

Alexandria Real Estate: The Uncertainty Is Real, But The Discount Has Gone Too Far

Alexandria Real Estate Equities, Inc. faces severe headwinds from oversupply and high vacancy in core life science markets, leading to an 80% stock decline from peak. ARE's undiversified exposure to B